Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs

Yuanhao Yu; Shiyi Zuo; Jiaxuan Song; Lingxiao Li; Tian Liu; Jiayu Guo; Yaqiao Li; Danping Wang; Qi Lu; Helin Wang; Dun Zhou; Zhonggui He; Xiaohong Liu; Bingjun Sun; Jin Sun

doi:10.1007/s12274-024-6611-8

Nano Research https://doi.org/10.1007/s12274-024-6611-8

Erratum | Online first | Published: 20 March 2024

Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs

Show Author's Information Hide Author's Information Yuanhao Yu^{¹^,^§}, Shiyi Zuo^{²^,^§}, Jiaxuan Song^{²^,^§}, Lingxiao Li^², Tian Liu^², Jiayu Guo^², Yaqiao Li^², Danping Wang^¹, Qi Lu^², Helin Wang^², Dun Zhou^³, Zhonggui He^², Xiaohong Liu^¹(

), Bingjun Sun^{²^,⁴}(

), Jin Sun^{²^,⁴}(

)

1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

2Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China

3Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China

4Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China

^§ Yuanhao Yu, Shiyi Zuo, and Jiaxuan Song contributed equally to this work.

Keywords:

albumin, doxorubicin, nanomedicines, fatty acid prodrug, pH-sensitive bond

The online version of the original article can be found at https://doi.org/10.1007/s12274-024-6533-5

Cite this article:

Yu Y, Zuo S, Song J, et al. Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs. Nano Research, 2024, https://doi.org/10.1007/s12274-024-6611-8

Download citation

EndNote(RIS)

BibTeX

Views

Downloads

Citations

Crossref

WoS

Scopus

CSCD

Full text About this article

Full text

Outline

About this article

Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs

Show Author's information Hide Author's Information Yuanhao Yu^{¹^,^§}, Shiyi Zuo^{²^,^§}, Jiaxuan Song^{²^,^§}, Lingxiao Li^², Tian Liu^², Jiayu Guo^², Yaqiao Li^², Danping Wang^¹, Qi Lu^², Helin Wang^², Dun Zhou^³, Zhonggui He^², Xiaohong Liu^¹(

), Bingjun Sun^{²^,⁴}(

), Jin Sun^{²^,⁴}(

)

1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

2Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China

3Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China

4Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China

^§ Yuanhao Yu, Shiyi Zuo, and Jiaxuan Song contributed equally to this work.

Keywords: albumin, doxorubicin, nanomedicines, fatty acid prodrug, pH-sensitive bond

About this article

Publication history

Published: 20 March 2024

Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs

Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs

Publication history

Copyright